BGM GroupBGM +13.07%53 Gross Margin % is 17.55% as of Mar. 2025. GuruFocus rates BGM with a GF Score™ of 53/100. Among 935 Drug Manufacturers companies, BGM Group ranks worse than 91.12% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. BGM Group's Gross Profit for the
six
months ended in Mar. 2025 was $2.51 Mil. BGM Group's Revenue for the
six
months ended in Mar. 2025 was $14.31 Mil. Therefore, BGM Group's Gross Margin % for the quarter that ended in Mar. 2025 was 17.55%.
The historical rank and industry rank for BGM Group's Gross Margin % or its related term are showing as below:
BGM's Gross Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 48.54 * Ranked among companies with meaningful Gross Margin % only.
BGM Group had a gross margin of 17.55% for the quarter that ended in Mar. 2025 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for BGM Group was 0.00% per year.
BGM Group (NAS:BGM) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
BGM Group had a gross margin of 17.55% for the quarter that ended in Mar. 2025 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
BGM Group Gross Margin % Related Terms
BGM Group Gross Margin % Historical Data
* Premium members only.
The historical data trend for BGM Group's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BGM vs INCR, SCYX, CTOR: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, BGM Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BGM Group Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, BGM Group's Gross Margin % distribution charts can be found below:
* The bar in red indicates where BGM Group's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
BGM Group (BGM) has a Gross Margin % of 17.55% as of Mar. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on BGM Group and its competitors. According to the industry distribution chart, BGM Group ranks #852 out of 935 companies in the Drug Manufacturers industry, placing it in the top 91.1%.
Is BGM Group's Gross Margin % too high?
BGM Group's current Gross Margin % is 17.55%. The Drug Manufacturers industry median Gross Margin % is 48.54. BGM Group's value of 17.55% is 63.8% below this industry median. Based on the distribution chart, BGM Group ranks #852 out of 935 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, BGM Group has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does BGM Group's Gross Margin % compare to INCR and SCYX?
According to the Drug Manufacturers industry distribution chart, BGM Group ranks #852 out of 935 companies for Gross Margin %. This places BGM Group in the lower half of its industry. The industry median Gross Margin % is 48.54. BGM Group's value of 17.55% is 63.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BGM Group's current Gross Margin % of 17.55% is 63.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on BGM Group and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BGM Group's current Gross Margin % is 17.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BGM Group stock overvalued right now?
BGM Group (BGM) has a current Gross Margin % of 17.55%. The current Gross Margin % is 17.55% and 63.8% below the Drug Manufacturers industry median of 48.54. BGM Group's overall GF Score™ is 53/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For BGM Group (BGM), the current Gross Margin % is 17.55% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
53GF Score
Get the complete analysis for BGM
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BGM has been successfully added to your 
